Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
Blood
|
November 30, 2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu Estey, David Grimwade, et al.
Blood
|
March 10, 2011
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
Giuseppe Avvisati, Francesco Lo-Coco, Francesca Paola Paoloni, et al.
Blood Cancer Journal
|
August 27, 2020
Characterization of FLT3-ITD<sup>mut</sup> acute myeloid leukemia: molecular profiling of leukemic precursor cells
Serena Travaglini, Daniela Francesca Angelini, Valentina Alfonso, et al.
Blood
|
July 21, 2010
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Francesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, et al.
Blood
|
July 25, 2008
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
Syed Khizer Hasan, Ashley N Mays, Tiziana Ottone, et al.
Nature Medicine
|
April 8, 2015
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Shuo Wei, Shingo Kozono, Lev Kats, et al.
British Journal of Haematology
|
May 7, 2014
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study
Antonio R Lucena-Araujo, Haesook T Kim, Rafael H Jacomo, et al.
Blood
|
May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Blood Advances
|
January 4, 2018
Clinical impact of <i>BAALC</i> expression in high-risk acute promyelocytic leukemia
Antonio R Lucena-Araujo, Diego A Pereira-Martins, Luisa C Koury, et al.
The New England Journal of Medicine
|
June 24, 2017
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
Richard M Stone, Sumithra J Mandrekar, Ben L Sanford, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
Blood
|
November 30, 2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu Estey, David Grimwade, et al.
Blood
|
March 10, 2011
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
Giuseppe Avvisati, Francesco Lo-Coco, Francesca Paola Paoloni, et al.
Blood Cancer Journal
|
August 27, 2020
Characterization of FLT3-ITD<sup>mut</sup> acute myeloid leukemia: molecular profiling of leukemic precursor cells
Serena Travaglini, Daniela Francesca Angelini, Valentina Alfonso, et al.
Blood
|
July 21, 2010
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Francesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, et al.
Blood
|
July 25, 2008
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
Syed Khizer Hasan, Ashley N Mays, Tiziana Ottone, et al.
Nature Medicine
|
April 8, 2015
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Shuo Wei, Shingo Kozono, Lev Kats, et al.
British Journal of Haematology
|
May 7, 2014
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study
Antonio R Lucena-Araujo, Haesook T Kim, Rafael H Jacomo, et al.
Blood
|
May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Blood Advances
|
January 4, 2018
Clinical impact of <i>BAALC</i> expression in high-risk acute promyelocytic leukemia
Antonio R Lucena-Araujo, Diego A Pereira-Martins, Luisa C Koury, et al.
The New England Journal of Medicine
|
June 24, 2017
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
Richard M Stone, Sumithra J Mandrekar, Ben L Sanford, et al.
Page
of 21